my Leadership approach is founded on trust, open dialogue and a collaborative approach to mutual success. key strengths include the ability to set, develop and continuously motivate the right team – whether it is as part of the management team setting the direction for the whole company or developing my own division, Sales- or Marketing teams.
when it comes to Sales and Marketing i am told that i have a strong commercial focus combined with a clear sight for Strategy development and execution. i have launched several new products and indications, build and commercialised new Therapeutic Areas, accelerated the growth of existing products and not least collaborated successfully with r&d on pipeline development to drive future growth.
i have a track record of creating solid results and have been describe as a motivating communicator capable of making significant impact on internal and external stakeholders. when it comes to business decisions they are always taken on the basis of customer insight, objective Analysis of the facts at hand and a clear focus on driving the overall performance of the company more than individual or team performance.
key strengths & personal competencies
• Strategy development & execution (pipeline & inline)
• market, brand & service development
• Sales force excellence
• developing customer & stakeholder relationships
• focus on achieving company and not only division, team or individual objectives
• commercial, result oriented mind-set
Sr. Director, Global Commercial Lead, Head of Patient Solutions AK (Global Marketing)Denmark / Global responsebility
Since October 2013
global commercial lead for our franchise within skin Cancer (ak & nmsc):
• accountable for the global, commercial Strategy
• provide commercial guidance to regions & markets
• provide commercial guidance to r&d ensuring development projects are founded on patient insights and fit for market needs
• support Business Development in ad hoc assessments
• lead, Coach and develop the global patient solutions team (marketing) as well as the extended global brand team direct reports: 5 (incl. 2 managers)
Member of the Global Dermatology leadership team, Reports to VP of Global Patient Solutions (Global Marketing). Promoted from Director to Sr. Director May 2014.
Member of LEO100 – the top leadership team in LEO Pharma.
Global commercial lead for our franchise within skin cancer (AK & NMSC):
• Accountable for the global, commercial strategy
• Co-lead the ingenol asset management group (AMG) driving the long-term pipeline strategy
• Provide commercial guidance to regions & markets
• Provide commercial guidance to R&D ensuring development projects are founded on patient insights and fit for market needs
• Support Business Development in ad hoc assessments
• Lead, coach and develop the global patient solutions team (marketing) as well as the extended global brand team Direct reports: 5 (incl. 2 managers)
Director, Global Commercial Lead, Head of Patient Solutions AK (Global Marketing)October 2013 --- April 2014
Member of the global Dermatology Leadership team, reports to vp of global patient solutions (Global Marketing) promoted to sr. Director may 2014 global commercial lead for our franchise within skin Cancer (ak & nmsc).
Head of Commercial Operations, Respiratory (Branded Generics & devices)March 2012 --- September 2013
Member of the nordic management team, reported to the nordic country head p & l responsibility for the Respiratory product portfolio with the key task of establishing a new business unit in order to prepare for the launch of a number of first in class, branded generics with significant potential: • develop the nordic “go to market” Strategy incl. organisational setup, Market access & Reimbursement, Sales, Marketing & medical / regulatory Strategy • Business Development & in-Licensing • establish sandoz as a new player within the Respiratory disease area (asthma, copd) team members: initial increase from 0 to 12 employees within my team
Business Unit Director, Neuroscience & Business OperationsAugust 2006 --- February 2012
promoted to business unit Director following mercks acquisition of schering-plough in q4 2009. Member of the danish Leadership team. reported to the General Manager of msd denmark. p & l responsibility for the Neuroscience portfolio & diversified brands as well as a newly established strategic support organisation working across all business units. • lead, Coach & develop the team • ensure the right Strategy is developed & implemented for the department and through membership of the Leadership team for the whole affiliate • establish msd as a new player within Neuroscience through the launch of a new antipsychotic agent with significant potential • develop a portfolio Strategy for diversified brands • develop a integrated strategic business support function, incl. multi channel Marketing, Project Management (lean / Six Sigma), crm, Market research and Event Management team members: 8 to 11 direct references and a total of 13 to 17 employees
Business Unit Manager, Primary Care (merged with MERCK)August 2006 --- December 2009
Member of the danish management team. reported to the General Manager of schering-plough denmark. following mercks acquisition of schering-plough in q4 2009 i was promoted to business unit Director within the new organisation (effective january 2010) p & l responsibility for the primary care portfolio focusing on allergy, Cardiology, Endocrinology & a large tail portfolio. • lead, Coach & develop the primary care team • ensure the right Strategy is developed & implemented for the department and through membership of the management committee for the whole affiliate • maximizing the success of our joint venture with msd • cross-functional responsibility for Market research, crm management and general Education in Sales & Marketing team members: 6 direct references and a total team of 19 employees
Sr. Product Manager, Cardiometabolic disease / ObesityMay 2005 --- July 2006
responsible for the pre-launch of acomplia (rimonabant) expected to be the first blockbuster product after the merger of the two companies.
Brand Manager, CNS (Schizophrenia)April 2004 --- April 2005
responsible for Marketing of denmark’s largest antipsychotic zyprexa (olanzapine) with a turnover of ~200 mdkk. key focus was on the main indication schizophrenia, including Forecasting, brand plan, budget & key opinion Leader development as well as Education and motivation of the sales force. team members: Sales Manager for 2 representatives and a Marketing assistant
International Group Product Manager, DermatologySeptember 2002 --- March 2004
part of a team of 3-4 people having the overall responsibility for developing the international strategies for the psoriasis portfolio in addition to supporting, motivating and reviewing the performance of affiliates and regional offices.
Brand Manager, CNS (Bipolar & BPSD)December 1998 --- August 2002
responsible for Marketing of denmark’s largest antipsychotic zyprexa (olanzapine). my responsibilities were primarily related to pre-launch and launch of two new indications, bipolar disorder and Treatment of behavioural and psychotic symptoms of dementia (bpsd).
Product Manager, ParkinsonJuly 2000 --- April 2001
responsible for the promotion of eli lilly’s parkinson drug, permax (pergolid).
Marketing AssociateDecember 1998 --- November 1999
successfully established a new Market research and crm function in the danish organisation.
Travel guideDecember 1995 --- April 1996
responsible for up to 180 danish skiing tourists per week in canazei, italy
Master of Science (M.Sc.) in International Marketing & Management from Copenhagen Business School in 1998
Bachelor (HA) in Economics, Business Administration & Languages from Syddansk Universitet in 1995
B.Sc. in Business Studies from Sheffield Hallam University in 1994
HH in Business Economics from Vejle Handelsskole in 1992
10 klasses afgangseksamen in from Kirkebakkeskolen, Vejle (Primary & lower secondary school) in 1989
Executive course in Powering Growth from INSEAD in 0000
Training and Certification
Masterclass in Digital transformation in 2017 Training
Leading Execution, Top100 program at LEO Pharma in 2016 Training
Powering Growth, Executive course at INSEAD in 2012 Training
Lean Six Sigma Executive Belt in 2011 Certification